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Abstract
Gene expression profiling across various brain areas at the single-cell resolution enables the identification of molecular
markers of neuronal subpopulations and comprehensive characterization of their functional roles. Despite the scientific
importance and experimental versatility, systematic methods to analyze such data have not been established yet. To
this end, we developed a statistical approach based on in situ hybridization data in the Allen Brain Atlas and thereby
identified specific genes for each type of neuron in the ventral tegmental area (VTA). This approach also allowed us to
demarcate subregions within the VTA comprising specific neuronal subpopulations. We further identified WW domain-
containing oxidoreductase as a molecular marker of a population of VTA neurons that co-express tyrosine hydroxylase
and vesicular glutamate transporter 2, and confirmed their region-specific distribution by immunohistochemistry. The
results demonstrate the utility of our analytical approach for uncovering expression signatures representing specific cell
types and neuronal subpopulations enriched in a given brain area.
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Introduction
The brain is an extremely complicated organ containing
myriad regions for the distinct processing and integration
of neural information. These regions are composed of di-
verse subregions, only some of which have been character-
ized thus far. To understand the functional roles of
individual neural circuits, the primary resident neuron types
must first be identified. Conventionally, neuron types have
been classified in accordance with their morphology, con-
nectivity, and electrophysiological features [1–3]. There is a
limited set of established markers for neuron types, and the
expression patterns of many genes remain uncharacterized
[4]. Currently, in situ hybridization (ISH) data are available
in the Allen Brain Atlas (ABA), providing brain-wide gene
expression profiles in adult mice, particularly at the single-
cell resolution [5, 6]. The ISH data provide opportunities to
search and pinpoint genes that were selectively expressed
in neuronal subpopulations [7, 8]. The select genes can
then serve as molecular signatures that represent these
neurons.
ISH data in the ABA have been used to identify neur-
onal subpopulations whose functions were investigated
with genetic animal models. For instance, Elfn1 is
expressed by subpopulations of interneurons within the
oriens-lacunosum moleculare area of the hippocampus
and confers target-specific synaptic properties [9]. Hence,
the identification of the neuronal subpopulation by a
marker gene led to the functional characterization of the
subregion in which they mainly reside. However, the ISH
data are not in an easily accessible format, which would
deter systematic searches for genes expressed specifically
in subpopulations.
The ventral tegmental area (VTA) is a midbrain
dopamine-producing center that is causally involved in
emotional states such as motivation and reward [10, 11].
The VTA largely comprises dopaminergic, glutamater-
gic, and GABAergic neurons that express the key en-
zymes for the synthesis and release of their respective
neurotransmitters [12, 13]. However, it is not clear
whether cellular identity can be systematically analyzed
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by profiling gene expression in each subregion of the
VTA or which genes are selectively expressed by each
cell type. To address these questions, we developed and
applied analytical approaches for identifying molecular
markers of the neuronal subpopulations enriched in
VTA subregions. This newly developed experimental al-
gorithm provided a set of unanticipated genes as mo-
lecular markers of VTA cell types.
Materials and methods
Identification of alternative marker genes
To identify potential marker genes for glutamatergic, dopa-
minergic, and GABAergic neurons in the VTA, for 1143
genes with the data available, Spearman’s correlations of their
expression intensities in the 42 voxels of the VTA were cal-
culated with the expression intensities of the following three
known maker genes: tyrosine hydroxylase (TH; the enzyme
required for dopamine synthesis), vesicular glutamate trans-
porter 2 (VGLUT2; encoded by Slc17a6), and glutamate de-
carboxylase 67 (GAD67; encoded by Gad1). P values of the
correlations between the genes and those known marker
genes for the null hypothesis (i.e., gene is not correlated with
the markers) were estimated according to a t test [14] previ-
ously described for the correlation coefficient. The correla-
tions with P < 0.05 were considered to be statistically
significant, and thereby marker candidates were selected as
the genes with significant positive correlations uniquely with
a known marker gene. Those genes having significant posi-
tive correlations with each used marker gene could show sig-
nificant (P < 0.05) negative correlations with the other
marker genes. On the basis of the correlation patterns (posi-
tive, negative, or no significant correlation) with the known
marker genes, the selected candidate genes were grouped
into 11 clusters. The final marker candidates were genes that
correlated positively with the neuron type of interest, but
correlated negatively with the other two neuronal types.
Identification of marker genes for neurons co-releasing
dopamine and glutamate
A virtual expression profile of a marker gene for neurons
co-releasing dopamine and glutamate was constructed
by taking the minimum expression levels of Th and
Slc17a6 across the grid voxels of the VTA, assuming
that these values would be the maximum expression
levels achieved by neurons expressing both Th and
Slc17a6. To identify marker candidates for the co-
releasing neurons, Spearman’s correlation values were
calculated between the expression profiles of each candi-
date gene in the grid voxels of the VTA and the virtual
expression profile. The P value of the correlation was
computed according to the t test mentioned above. The
marker candidate genes for neurons co-releasing dopa-
mine and glutamate displayed positive correlation with a
P value of < 0.05.
Animals and tissue preparation
Male C57BL/6 J mice were housed under a 12-h light/
dark cycle with ad libitum access to food and water. All
procedures for animal experiments were approved by
the ethical review committee of POSTECH (Pohang
University of Science & Technology), Korea, and
performed in accordance with the relevant guidelines.
Mice were anesthetized by intraperitoneal injection of
Avertin (250 mg/kg body weight, T48402; Sigma) and
transcardially perfused with PBS followed by 4% formal-
dehyde. The brains were isolated, postfixed overnight at
4 °C in a 4% formaldehyde solution, and embedded in
5% agarose gel for sectioning (50-μm-thick coronal sec-
tions) with a vibratome (VT1000S; Leica, Germany). Tis-
sue sections containing the VTA region according to the
mouse brain atlas [15] were collected.
Immunohistochemistry
For immunohistochemistry (IHC), prepared tissues were
blocked with 4% normal donkey serum and 0.4% Triton
X-100 in PBS at 4 °C for 1 h and then incubated with the
following primary antibodies at 4 °C overnight: rabbit
anti-P2RY14 (1:500, 20,190–1-AP; Proteintech), rabbit
anti-CHRNA6 (1:500, GTX51236; GeneTex), rabbit or
sheep anti-TH (1:1000, AB152 or AB1542; Millipore),
mouse anti-GAD67 (1:500, MAB5406; Millipore), goat
anti-VGLUT2 (1:500, ab79157; Abcam), and rabbit anti-
WWOX (1:500, sc-366,157; Santa Cruz Biotechnology).
Donkey anti-goat DyLight 488-conjugated IgG or don-
key anti-sheep DyLight 550-conjugated IgG (1:500;
Bethyl Laboratories) and donkey anti-rabbit Alexa 647-
conjugated IgG (1:500; Abcam) were used as secondary
antibodies. All tissues were mounted on glass slides
using UltraCruz mounting medium containing DAPI
(Santa Cruz Biotechnology).
Cellular imaging and quantification
Sections were imaged with a laser scanning confocal
microscope (LSM 510; Zeiss, Germany) with 40× lens
objective (C-Apochromat 40 × /1.2W Korr; scanning
area, 230 × 230 μm2; image resolution, 1024 × 1024
pixels). Quantitative analysis of immunoreactive signals
was performed using MetaMorph 7.7 software (Molecu-
lar Devices, Sunnyvale, CA) and Image J (NIH, Bethesda,
MD). To estimate the neural cell count within each
voxel (200 × 200 × 200 μm3), we first counted the cells
within a cube of 50 × 200 × 200 μm3 as follows (Fig. 1e):
1) we generated 10 z-stacked images (200 × 200 μm2) to
cover 50 μm in height, 2) we combined these images to
generate a 2-D projected image, and 3) then counted
cells in the 2-D projected image. We next estimated the
cell number in a voxel by multiplying 4 into the cell
number counted from 50 × 200 × 200 μm3. This proced-
ure was performed for 20 projected images from the 12
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distinct sampling locations in the VTA (Fig. 2b), and the
average cell count was obtained. In the experiments
using different brain slices, we tried to capture all IHC
images from the VTA locations indicated in Fig. 2a,
which effectively covers the VTA [15]. To further clarify
the location information, we assigned IDs to the sam-
pling locations, M1–6 and L1–6, in Fig. 2a and used
these IDs to indicate the locations from which the
representative images were obtained. Mander’s overlap
coefficient was calculated by the Coloc2 plugin function
of Image J.
Experimental design and statistical analysis
For quantification of neurons expressing marker pro-
teins in the VTA, we conducted IHC experiments at the
sampling locations of M and L indicated in Fig. 2a. In
Fig. 1 Gene expression profiles across voxels in the VTA. (a) Overall scheme of the analytical approach involving (i) data acquisition from the ABA,
(ii) data analysis (correlation-based gene classification and selection of marker candidates), and (iii) validation of the candidates. (b) Spatially annotated
voxels encompassing the VTA. The VTA volume is split into the subregions from the center along the AP, ML, and DV axes, and the 42 voxels were
assigned into the subregions after mapping the voxels into the VTA volume. Cross-section views (AP-LM, AP-DV, and LM-DV) show how voxels are
divided by the AP, ML, and DV axes. Different colors are used to denote the voxels at the four quadrants in the cross-sections. (c) Gene expression
intensity is estimated for each voxel. For gene i, expression intensity was estimated as the sum of expressing pixel intensities divided by the sum of
expressing pixels from four ISH images covering a voxel. (d) Gene expression matrix for m genes and n voxels (m = 1143 and n = 42). Element (i, j) in
the matrix indicates expression intensity for gene i and voxel j. e. Estimation of the cell count in a unit area (left) and a voxel (right). Neuronal cells
were labeled with selective neuronal cell marker, NeuN (red) and imaged at 12 distinct sampling points of the VTA region. For cell counting in each
voxel, 10 z-stacked images covering a cube of 50 × 200 × 200 μm3 (left) were combined to generate a 2-D projected image from which cells were
counted, and the cell count was then multiplied by 4. The average numbers of neuronal cells were calculated and used to determine proportional cell
populations (3 mice and 10 brain slices, M location: 10 images, L location: 10 images)
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these experiments, we used the following numbers of an-
imals and images: for NeuN+ counting, N = 3, 10 brain
slices, M location: 10 images, L location: 10 images; for
TH-GAD67-VGLUT2 triple labeling, N = 4, 13 brain
slices, M location: 11 images, L location: 9 images; for
TH-CHRNA6 double labeling, N = 3, 11 brain slices, M
location: 7 images, L location: 7 images; for VGLUT2-
P2RY14 double labeling, N = 3, 11 brain slices, M loca-
tion: 6 images, L location: 6 images; and for TH-
VGLUT2-WWOX triple labeling, N = 6, 22 brain slices,
M location: 22 images, L location: 14 images).
Results
Analytical algorithms for gene expression profiles in the
VTA
To parse gene expression profiles in the VTA, we first
selected a grid of 42 voxels (200 × 200 × 200 μm3)
encompassing the VTA according to the annotated
three-dimensional reference spaces reconstructed based
on ISH and magnetic resonance imaging data in the
ABA (Fig. 1a and b). For each gene, expression intensity
in each voxel was calculated as the sum of the pixel in-
tensity divided by the sum of expressing pixels from four
ISH images (intensity/pixel, Fig. 1c), using the three-
dimensional expression grid data. Expression intensities
for the 1143 genes available from the coronal section
dataset in the 42 voxels were obtained, resulting in a
1143 × 42 gene expression intensity matrix (Fig. 1d). For
further cellular quantification, we estimated neuronal
cell numbers in brain tissue sections by IHC with a se-
lective neuronal cell marker. Empirically, there were
916.82 ± 33.77 and 365.63 ± 9.28 neuronal cells included
in a unit area (mm2) and in a voxel (200 × 200 ×
200 μm3), respectively, in the VTA (Fig. 1e).
IHC analysis of the VTA
Next, we performed IHC analysis of the VTA using anti-
bodies against TH, VGLUT2, and GAD67 to label dopa-
minergic, glutamatergic, and GABAergic neurons,
respectively. The numbers of each neuron type were
counted from 20 images taken at sampling regions along
the anterior-posterior axis (indicated in Fig. 2a) to en-
compass the entire VTA region from multiple mice.
GAD67+ cells were not largely co-localized with other
cell types, but TH+ and VGLUT2+ cells were partially
co-localized (Fig. 2b). The proportions of TH+,
VGLUT2+, and GAD67+ neurons were estimated to be
70, 22, and 16%, respectively, of the population of
Fig. 2 Neuron subpopulations estimated from IHC analysis of the VTA. (a) VTA region enriched with dopaminergic neurons (green); red, GAD67
signal. The corresponding atlas maps along the anterior-posterior axis are shown at the bottom (red shading, VTA). Colored squares indicate
sampling sites (light blue dotted line indicates medial-lateral separation, 0.5 μm apart from central of the atlas). L1–6 and M1–6 were used to
indicate the locations from which the IHC images are obtained. (b) Triple immunolabeling for TH+ (blue), GAD67+ (red), and VGLUT2+ (green)
neurons in the VTA (4 mice and 13 brain slices, M location: 11 images, L location: 9 images). The representative images were obtained from M3
location in a. (c Proportions of neuron types in the VTA based on the average number of NeuN+ cells (see Fig. 1e; 916.82 ± 33.77 cells/mm2)
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NeuN+ cells (set at 100%, see Fig. 1e) (Fig. 2c), which is
consistent with previous findings [16, 17]. The
remaining 2% of neurons had no detectable expression
of TH, VGLUT2, or GAD67. Interestingly, 10% of the
neurons expressed both TH and VGLUT2 (see TH-
VGLUT2+ neuron in Fig. 2b), suggesting that the VTA
contains a substantial proportion of neurons that co-
release dopamine and glutamate.
Alternative marker genes to Th, Slc17a6, and Gad1
To demonstrate the utility of the ISH data in the ABA,
we first attempted to identify genes that showed similar
expression profiles to the known marker genes, Th,
Slc17a6, and Gad1, across the 42-voxel grid in the VTA.
To this end, we calculated Spearman’s correlations for
the expression intensity of Th, Slc17a6, or Gad1 with
those of the 1143 genes in the 42 voxels and then esti-
mated the significance (P value) of the correlation for
each marker gene pair. Using this algorithm, the expres-
sion profiles of 539, 422, and 336 genes positively or
negatively correlated significantly (P < 0.05) with those
of Slc17a6, Th, and Gad1, respectively (Fig. 3a). Among
these, we selected 171, 231, and 179 genes whose ex-
pression intensity patterns were positively correlated
uniquely to those of Slc17a6, Th, and Gad1, respectively
(Fig. 3b–e). Interestingly, anticorrelations were found be-
tween proportions of these genes, which may better dis-
tinguish these cell types. For example, among the 231
Th-like genes, 47 and 9 showed significant (P < 0.05)
anticorrelations with Slc17a6 and Gad1, respectively.
Similar anticorrelated gene sets were identified from the
Slc17a6-like genes (68 genes anticorrelated with Gad1,
12 genes with Th, and three genes with both) and the
Gad1-like genes (18 genes anticorrelated with Th, 104
genes with Slc17a6, and 16 genes with both). These
genes included previously known marker genes for
dopaminergic and GABAergic neurons, namely Slc6a3
[18, 19] and Drd2 [18] in Th-like genes and Gad2 [20]
and Slc32a1 [21] in Gad1-like genes, respectively (Fig.
3b). These data support the utility of the ISH data in the
search for potential marker genes associated with the
primary neuron types in the VTA.
Distributions of distinct neuron types in the VTA
The search for alternative marker genes resulted in novel
candidates for Th+, Slc17a6+, and Gad1+ neurons. We
determined whether their expression in the VTA corre-
lated with Th, Slc17a6, and Gad1 expression using the
ISH images in the ABA and selected the top five novel
marker candidates for each neuronal type (Fig. 4a and
b). From these results, we selected Chrna6 and P2ry14
from the Th- and Slc17a6-like genes, respectively (Fig.
4b and c) for further analysis; none of the top five Gad1-
like candidates showed expression patterns similar to
that for Gad1 based on the ISH data.
We further examined the anatomical distribution of
Th, Slc17a6, and Gad1, as well as the alternative marker
candidates, in the VTA via the ISH images. Th+ and
Chrna6+ neurons were distributed throughout the VTA
as well as in the substantia nigra pars compacta area
(Fig. 4c, top row). Slc17a6+ and P2ry14+ neurons were
enriched in the medial part of the VTA, with P2ry14 also
Fig. 3 Alternative marker genes to Slc17a6, Th, and Gad1. (a) Venn diagram showing relationships among Slc17a6-, Th-, and Gad1-like genes.
Numbers of genes belonging to individual clusters are shown. (b–d) Heat maps showing similar expression between the selected candidates and
Slc17a6 (b), Th (c), and Gad1 (d). Blue triangles indicate guide points for designation of medial (left, voxels 1–26) and lateral (right, voxels 27–42).
Expression intensity for each gene was autoscaled to yield a mean of 0 and a standard deviation of 1 (red, positive; blue, negative). e Correlation
patterns of Slc17a6-, Th-, and Gad1-like genes. These three groups of genes were categorized into 11 clusters (C1–11) based on their correlations
(positive, red; negative, blue) with Slc17a6, Th, and Gad1
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distributed weakly in the substantia nigra pars reticu-
lata (Fig. 4c, middle row). By contrast, Gad1+ cells
were distributed peripherally around the VTA and in
the substantia nigra pars reticulata (Fig. 4c, bottom).
These data suggest that the anatomical distribution of
neurons expressing the marker genes can potentially
be used to identify subregions in the structures in
which they reside. To assess the validity of P2ry14
and Chrna6 as marker genes, we performed IHC to
examine the expression of P2RY14 and CHRNA6 in
VGLUT2+ and TH+ cells (Fig. 4d). Quantification of
the numbers of single- and double-positive cells con-
firmed that the expression of these genes can be used
as reliable markers of individual cell types (Fig. 4e).
Collectively, the data described above support the
utility of our analytical approach for identifying
marker genes for neuronal subpopulations as well as
their distribution in the VTA.
Marker genes for neurons co-releasing dopamine and
glutamate
The IHC analysis confirmed that a subpopulation of
neurons in the VTA co-express TH and VGLUT2 (Fig.
2b and c), which can be considered neurons that co-
release dopamine and glutamate [13, 16]. Since there are
no faithful marker genes for these co-releasing neurons,
we sought to examine their gene expression profiles in
the VTA. We first computed the minimum expression
intensities of Th and Slc17a6 in individual voxels (Fig. 5a,
gray shading area), assuming these intensities are the
maximum that can originate from neurons co-
expressing TH and VGLUT2. Using this idea, we
Fig. 4 Distribution of neuron subpopulations in the VTA. (a) Schematic showing the procedure for selecting the final marker candidates from
Slc17a6-, Th-, and Gad1-like genes. See the text for details. (b) Top five alternative marker candidates were selected from Slc17a6- and Th-like
genes, and conventional markers were listed with or without a final candidate (red) for each type of neuron. Spearman’s correlations (Rho) are
shown, along with their P values. (c) ISH images showing expression of the indicated genes at the single-cell resolution. Axes: D, dorsal; V, ventral;
M, medial; L, lateral. (d) Representative IHC images showing expression of the indicated proteins. The images were obtained from M2 and M6
locations in Fig. 2a for visualizing of P2RY14-VGLUT2 labeling and CHRNA6-TH labeling, respectively. (e) Numbers of neurons expressing the
indicated proteins (3 mice and 11 brain slices per marker candidate; for Slc17a6 like [M location: 6 images, L location: 6 images], for Th like [M
location: 7 images, L location: 7 images] used for analysis). Data are shown as mean ± SEM. Slc17a6-like: VGLUT2+, 77.71 ± 19.03 cells/mm2;
P2RY14+, 71.41 ± 16.63 cells/mm2; double-positive (co-local.), 67.21 ± 14.22 cells/mm2; Th-like: TH+, 484.62 ± 26.90 cells/mm2; CHRNA6+, 500.95 ± 29.60
cells/mm2; co-local., 474.48 ± 14.22 cells/mm2
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identified 191 genes with expression intensities that cor-
related significantly (P < 0.05) with the minimum inten-
sities of Th and Slc17a6 (Fig. 5b). We then selected the
top five candidates (Fig. 5c) and examined ISH images
to determine whether they are co-expressed with Th and
Slc17a6 in the VTA. We selected the gene encoding
WW domain-containing oxidoreductase (Wwox), whose
expression pattern was most similar to that of Slc17a6
(Fig. 5d), overlapped with Th (Fig. 4c, top left), and was
consistent with the minimum expression profiles of Th
and Slc17a6 (Fig. 5a). To confirm Wwox as a marker of
TH- and VGLUT2- co-expressing neurons, we per-
formed an IHC analysis (Fig. 6a) and a pixel-level ana-
lysis of fluorescence signals using Mander’s overlap
coefficient (Fig. 6a and b). The IHC data showed that >
70% of the neurons that expressed WWOX also
expressed both TH and VGLUT2 (Fig. 6c) and were
enriched in the medial part of the VTA relative to the
lateral part (Fig. 6d and e), which was consistent with
the minimum expression profiles of Th and Slc17a6 (Fig.
5a). These data further support the utility of our analyt-
ical approach and algorithm in identifying novel marker
genes for a subpopulation of neurons and their distribu-
tion in the VTA.
Discussion
In this study, we analyzed gene expression intensities
within voxels encompassing the VTA. We estimated
from IHC that each voxel contained > 300 neurons and
thus may not allow for sufficient spatial resolution in
order to pinpoint marker gene expression in individual
cells. However, our results demonstrate that such data
can provide a list of useful marker candidates, such as
Th and Slc17a6 for dopaminergic and glutamatergic
neurons, respectively. Our analytical approach suggests
that the ISH data can identify marker candidates when
the variation in expression intensities across each voxel
serves as a representation of the variation in neuron sub-
populations in a specific region, such as the VTA.
Our systematic analytical approach involved super-
vised clustering of the genes based on correlation pat-
terns with the known markers (Th, Slc17a6, and Gad1)
to identify alternative markers for neuron subpopula-
tions in the VTA. However, this approach may be not
necessary, as we can perform unsupervised clustering of
the genes according to the similarity of their expression
patterns across the voxels in the grid. Each of the result-
ing clusters may represent a neuron subpopulation. In
this study, unsupervised clustering of the genes within
the 42-voxel grids in the VTA using the non-negative
matrix factorization method [22] provided four major
clusters that included Th, Slc17a6, Gad1, or both Th
and Slc17a6. These results were consistent with those
from our supervised clustering approach.
Although dopamine- and glutamate-co-releasing neu-
rons were previously identified [12, 13, 23], their cellular
features and functional consequences remain to be fully
clarified [13, 24, 25]. Their functional roles are just
Fig. 5 Marker genes for neurons expressing both Th and Slc17a6 in the VTA. (a) Virtual expression profile for a marker candidate of neurons expressing
both Th and Slc17a6. The virtual profile was defined as the minimum (red) Slc17a6 (green) and Th (blue) expression intensity. Gray shading indicates
the minimum expression level between Th and Slc17a6. The blue triangle indicates a guide point for designation of medial and lateral (voxels 1–26
and 27–42, respectively). (b) Heat map showing that the expression of the selected candidates is similar to that of the virtual expression profile.
Expression intensities for each gene were autoscaled to yield a mean of 0 and a standard deviation of 1 (red, positive; blue, negative). The blue triangle
indicates a guide point for medial and lateral as for panel a. (c) List of selected top five marker candidate genes for Th-Slc17a6 co-localized cells in the
VTA (final selected gene is in red). (d) ISH images showing expression of Slc17a6 and Wwox in the VTA
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beginning to be elucidated by conditional deletion of
Slc17a6 in VTA dopaminergic neurons or by targeted
analysis of Slc17a6/VGLUT2+ neurons in the VTA [26–
28]. However, these studies were unable to target the co-
releasing neurons selectively and failed to delineate their
impact on synaptic plasticity and animal behaviors. We
identified Wwox as a potential marker gene for these co-
releasing neurons, which may enable them to be modu-
lated in cell-type-specific and temporally dependent
fashions both in vitro and in vivo.
Previously, Wwox was shown to act as a tumor sup-
pressor whose loss of heterozygosity and chromosomal
rearrangement have been detected in various cancers in-
cluding ovarian, breast, hepatocellular, and prostate can-
cers [29]. Upon its phosphorylation at Tyr33 in the WW
domain, activated WWOX acquires enhanced interac-
tions with various transcription factors including p53, c-
Jun, TNF, p73, AP2 gamma, and E2f1. Recently, a num-
ber of studies have reported that Wwox plays important
roles also in the brain, and its dysregulation leads to
neurodegeneration [30]. For example, Wwox is downreg-
ulated in the hippocampi of patients with Alzheimer’s
disease [31], and knockdown of Wwox in neuroblastoma
cells and mice resulted in aggregation of amyloid β and
Tau [32]. However, the potential roles of Wwox in the
VTA have been rarely investigated. WWOX binds and
co-translates with many transcription factors to relocate
to the nucleus to enhance or block neuronal survival
under physiological or pathological conditions [33]. Our
finding suggests that Wwox can be induced highly in
dopamine- and glutamate-co-releasing neurons and se-
lective targeting of these co-releasing neurons using
Wwox may provide new insights into the roles of these
neurons in neuronal survival in the VTA, as well as ani-
mal behaviors associated with the VTA.
The number of genes with the expression intensity
available in the ABA continues to increase, which should
lead to more comprehensive searches of marker genes.
Moreover, the gene expression intensities from the sagit-
tal section datasets can be combined with those from
the coronal section datasets, and our analytical approach
can be applied to the combined gene expression profiles.
Genes that show specific expression in neuronal subpop-
ulations consistently in both coronal and sagittal section
datasets could be considered as more reliable candidates.
Therefore, our analytical approach is widely applicable
to the identification of various cellular marker genes in
various cellular contexts and brain areas.
Fig. 6 Validation of selected marker gene by IHC analysis. (a) Representative IHC images showing expression of the indicated proteins in the
medial part of the VTA. The images in the 3rd column show expression of WWOX (green), TH (blue), and VGLUT2 (red) in a subregion indicated
by the white dotted box in the merged image. The representative images were obtained from M3 location in Fig. 2a. (b) Mander’s overlap
coefficient (MOC) analysis was performed on IHC images. Pixel-based overlapped coefficients between green and blue (G:B), green and red (G:R),
and red and blue (R:B) channels, n = 10 cells. (c) Pie charts showing the proportions of WWOX expressing neurons expressing or not expressing
TH and/or VGLUT2 in the medial (left) and lateral (right) parts of the VTA (6 mice and 22 brain slices, M location: 22 images, L location: 14 images
were used for analysis). (d) Representative images showing medial and lateral distributions of neurons expressing WWOX (green), TH (blue) and
VGLUT2 (red). These images were obtained from M2 and L1 locations in Fig. 2a. (e) Bar graphs showing the numbers of neurons expressing the
indicated proteins in the medial (M) and lateral (L) regions of the VTA (image data same as c). Data are shown as mean ± SEM. M: TH+, 359.17 ± 28.98
cells/mm2; VGLUT2+, 224.48 ± 14.89 cells/mm2; WWOX+, 197.31 ± 16.10 cells/mm2; L: TH+, 407.78 ± 18.02 cells/mm2; VGLUT2+, 112.07 ± 5.77 cells/
mm2; WWOX+, 70.21 ± 6.08 cells/mm2
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Slc17a6; VTA: Ventral tegmental area; WWOX: WW domain-containing
oxidoreductase
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